CN110590668A - N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法 - Google Patents
N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法 Download PDFInfo
- Publication number
- CN110590668A CN110590668A CN201910646622.4A CN201910646622A CN110590668A CN 110590668 A CN110590668 A CN 110590668A CN 201910646622 A CN201910646622 A CN 201910646622A CN 110590668 A CN110590668 A CN 110590668A
- Authority
- CN
- China
- Prior art keywords
- compound
- pyrazol
- chloro
- preparation
- cyanophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910646622.4A CN110590668A (zh) | 2019-07-17 | 2019-07-17 | N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910646622.4A CN110590668A (zh) | 2019-07-17 | 2019-07-17 | N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110590668A true CN110590668A (zh) | 2019-12-20 |
Family
ID=68852836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910646622.4A Pending CN110590668A (zh) | 2019-07-17 | 2019-07-17 | N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110590668A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111087324A (zh) * | 2019-12-30 | 2020-05-01 | 杭州科巢生物科技有限公司 | 一种多拉米胺的合成方法 |
CN111116476A (zh) * | 2019-12-27 | 2020-05-08 | 武汉九州钰民医药科技有限公司 | 制备抗肿瘤药物多拉米胺的方法 |
CN111116477A (zh) * | 2019-12-27 | 2020-05-08 | 武汉九州钰民医药科技有限公司 | 多拉米胺的合成工艺 |
CN113527208A (zh) * | 2021-08-31 | 2021-10-22 | 江西金丰药业有限公司 | 一步法制备2-氯-4-(1h-吡唑-3-基)苯甲腈的方法 |
CN113861115A (zh) * | 2021-09-10 | 2021-12-31 | 浙江师范大学 | 一种吡唑酰胺类衍生物及合成方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102596910A (zh) * | 2009-10-27 | 2012-07-18 | 奥赖恩公司 | 雄激素受体调节化合物 |
WO2014153090A1 (en) * | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Pyrazole derivatives asprmt1 inhibitors and uses thereof |
WO2016120530A1 (en) * | 2015-01-30 | 2016-08-04 | Orion Corporation | A carboxamide derivative and its diastereomers in stable crystalline form |
CN107428695A (zh) * | 2015-04-09 | 2017-12-01 | 奥赖恩公司 | 用于制备雄激素受体拮抗剂及其中间体的方法 |
-
2019
- 2019-07-17 CN CN201910646622.4A patent/CN110590668A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102596910A (zh) * | 2009-10-27 | 2012-07-18 | 奥赖恩公司 | 雄激素受体调节化合物 |
WO2014153090A1 (en) * | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Pyrazole derivatives asprmt1 inhibitors and uses thereof |
WO2016120530A1 (en) * | 2015-01-30 | 2016-08-04 | Orion Corporation | A carboxamide derivative and its diastereomers in stable crystalline form |
CN107428695A (zh) * | 2015-04-09 | 2017-12-01 | 奥赖恩公司 | 用于制备雄激素受体拮抗剂及其中间体的方法 |
Non-Patent Citations (1)
Title |
---|
TINGTING PAN等: "Chemical synthesis of the ODM-201"s diastereomers through an efficient intramolecular 1,3-dipolar cycloaddition", 《CHEMICAL & PHARMACEUTICAL BULLETIN》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111116476A (zh) * | 2019-12-27 | 2020-05-08 | 武汉九州钰民医药科技有限公司 | 制备抗肿瘤药物多拉米胺的方法 |
CN111116477A (zh) * | 2019-12-27 | 2020-05-08 | 武汉九州钰民医药科技有限公司 | 多拉米胺的合成工艺 |
CN111087324A (zh) * | 2019-12-30 | 2020-05-01 | 杭州科巢生物科技有限公司 | 一种多拉米胺的合成方法 |
CN111087324B (zh) * | 2019-12-30 | 2022-11-11 | 杭州科巢生物科技有限公司 | 一种多拉米胺的合成方法 |
CN113527208A (zh) * | 2021-08-31 | 2021-10-22 | 江西金丰药业有限公司 | 一步法制备2-氯-4-(1h-吡唑-3-基)苯甲腈的方法 |
CN113861115A (zh) * | 2021-09-10 | 2021-12-31 | 浙江师范大学 | 一种吡唑酰胺类衍生物及合成方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110590668A (zh) | N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法 | |
CN107428695B (zh) | 用于制备雄激素受体拮抗剂及其中间体的方法 | |
JP2011184451A (ja) | 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法 | |
CN104066744A (zh) | 用于制备17-取代的甾体的方法 | |
CA2794003A1 (en) | Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use | |
CN104130258B (zh) | 一种二聚体的转化方法 | |
KR20110015703A (ko) | 발사르탄의 제조 방법 | |
WO2010140168A1 (en) | Improved process for preparing temozolomide | |
WO2014083512A1 (en) | Process for preparation of abiraterone acetate | |
CN102875537A (zh) | 一种新的抗血栓药物的制备方法 | |
CN108699068A (zh) | 一种三氟甲基取代的吡喃衍生物制备方法 | |
US6515128B2 (en) | Processes for preparing cilostazol | |
US8569492B2 (en) | Method for preparing halofuginone derivative | |
US20030166937A1 (en) | Substantially pure cilostazol and processes for making same | |
AU2001284887A1 (en) | Processes for preparing cilostazol | |
CN104768944B (zh) | 2‑吡啶酮化合物 | |
CN103539750A (zh) | 一种合成卢非酰胺的工艺 | |
WO2012004811A1 (en) | Process for the preparation of 5-substsituted indole derivative | |
US20070249839A1 (en) | Process for the Preparation of Losartan Potassium Form I | |
WO2014124594A1 (zh) | 一种克里唑替尼的制备方法 | |
CN107353256A (zh) | 一锅法合成4‑乙酰基‑1,2,3‑三唑化合物的方法 | |
CN109553609B (zh) | 一种卡格列净的制备方法 | |
CN112125849A (zh) | (2-(1h-咪唑-4-基)苯基)甲醇的制备方法 | |
WO2018108130A1 (en) | Process for preparation of novel androgen receptor antagonist | |
CN112094241B (zh) | 一种1,4-二氮杂螺[5,5]十一烷-3-酮的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 223800 No. 38 Yangzi Road, Eco-chemical Science and Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant after: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant after: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant after: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. Address before: 223800 No. 38 Yangzi Road, Eco-chemical Science and Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant before: JIANGSU JUNRUO PHARMACEUTICAL Co.,Ltd. Applicant before: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant before: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 223800 No. 38, Yangzi Road, ecological Chemical Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant after: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant after: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant after: Nantong Baikang biomedical Co.,Ltd. Address before: 223800 No. 38, Yangzi Road, ecological Chemical Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant before: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant before: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant before: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191220 |